Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.125 SEK | -0.79% | +15.22% | +11.58% |
30/04 | Transcript : Medivir AB, Q1 2024 Earnings Call, Apr 30, 2024 | |
30/04 | Medivir AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 10
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 4 | 100.0 % | 8 | 100.0 % | +73.16% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
46.9
%
| - | - | 4 | 46.9 % | - |
Europe, Other
43.3
%
| 4 | 80.8 % | 3 | 43.3 % | -7.16% |
Rest of the World
4.8
%
| 0 | 9.9 % | 0 | 4.8 % | -16.21% |
Sweden
2.5
%
| 0 | 5.0 % | 0 | 2.5 % | -13.12% |
Nordic Region, Other
2.4
%
| 0 | 4.2 % | 0 | 2.4 % | -0.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 24/22/24 |
Director of Finance/CFO | 50 | 12/19/12 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 03/18/03 |
Pia Baumann
CTO | Chief Tech/Sci/R&D Officer | 58 | 20/23/20 |
Malene Jensen
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/21/01 |
Fredrik Öberg
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/11/01 |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 26/20/26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 03/18/03 |
Director/Board Member | 68 | 03/18/03 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 26/20/26 |
Bengt Westermark
BRD | Director/Board Member | 79 | 03/17/03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 864,750 | 0 | 864,750 ( 100.00 %) | 68.69 % |
Stock B | 1 | 104,506,048 | 72,375,356 ( 69.25 %) | 11,413 ( 0.0109 %) |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.58% | 32.17M | |
-1.50% | 104B | |
+4.29% | 97.47B | |
+5.56% | 22.25B | |
-13.40% | 21.68B | |
-9.40% | 18.2B | |
-39.98% | 17.02B | |
-11.79% | 16.36B | |
+8.53% | 14.39B | |
+42.07% | 12.37B |
- Stock Market
- Equities
- MVIR B Stock
- Company Medivir AB